Day One Announces $130 Million Series B Financing to Accelerate New Targeted Cancer Treatments for Children
Amount Raised
$130 Million
Round Type
Series B
BrisbaneBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on accelerating new, promising targeted therapies for children and adults with cancer, today announced a $130 million Series B financing from leading life sciences investors. The financing was led by RA Capital Management with participation from additional new investors Boxer Capital, BVF Partners L.P., Franklin Templeton, Janus Henderson Investors, Perceptive Advisors, funds and accounts advised by T. Rowe Price Associates, Inc., and Viking Global Investors. Existing investors Canaan, Access Biotechnology, and Atlas Venture also participated.
Quick answer
Day One Biopharmaceuticals raised $130 Million in a Series B round, dated February 10, 2021. Day One Biopharmaceuticals is based in Brisbane, California, United States.
- How much did Day One Biopharmaceuticals raise?
- Day One Biopharmaceuticals raised $130 Million in a Series B round on February 10, 2021.
- What does Day One Biopharmaceuticals do?
- Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases.
- Where is Day One Biopharmaceuticals based and how big is it?
- Day One Biopharmaceuticals is based in Brisbane, California, United States. Fundz records about 51 employees.
- Who are the decision-makers at Day One Biopharmaceuticals?
- Fundz holds 2 contacts at Day One Biopharmaceuticals, including the Vice President, Talent. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Day One Biopharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Oragenics raised $21M (Series C) on February 12, 2021.
- ISOThrive raised $5.2M on February 5, 2021.
- Parabilis Medicines raised $23M on January 5, 2021.
- Azora Therapeutics, Inc. (DE) raised $291K on March 26, 2021.
- Camp4 Therapeutics Corp raised $15M on March 19, 2021.
- OnKure Therapeutics raised $29M on March 5, 2021.
Who to call at Day One Biopharmaceuticals, and when
A new round usually means Day One Biopharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Day One Biopharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Day One Biopharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Day One Biopharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Day One Biopharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansDay One Biopharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.